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them about their homing preference; upon systemicRetinoic Acid:
stimulation by antigen, activated T cells in mesentericAn Educational “Vitamin Elixir” lymph nodes (MLN; receiving afferent lymph from the
for Gut-Seeking T Cells gut) upregulate gut-homing molecules, whereas those
in peripheral lymph nodes (PLN, draining cutaneous tis-
sues) express skin-homing receptors (Campbell and
Butcher, 2002). This differential imprinting was repro-
duced in vitro by activating naive T cells with DC fromT cell priming by dendritic cells (DC) from gut-associ-
different lymphoid organs. Thus, DC from Peyer’sated lymphoid tissues gives rise to effector cells with
patches (PP) or MLN, but not from PLN or spleen, inducepronounced gut tropism. The mechanism for DC-depen-
effector T cells with high expression of 47 and CCR9dent imprinting of gut specificity has remained un-
and the capacity to migrate to the small bowel (Johans-known. New findings point to retinoic acid, which is
uniquely produced by intestinal DC, but not by DC son-Lindbom et al., 2003; Mora et al., 2003; Stagg et
from other lymphoid organs (Iwata et al., 2004; this al., 2002). However, until now, the mechanism(s) respon-
issue of Immunity). sible for this imprinting of tissue specificity has remained
a complete mystery.
A groundbreaking article in this issue of ImmunityWhen naive T cells are activated by antigen they become
identifies the first molecular mechanism for the im-effector/memory T cells, which acquire the capacity to
printing of gut-homing T cells (Iwata et al., 2004). Inmigrate to extralymphoid tissues (von Andrian and
an elegant series of experiments, Iwata and colleaguesMackay, 2000). Effector cells that arise in response to
show that T cell exposure to subnanomolar concentra-antigens in the alimentary tract express mostly intestinal
tions of the vitamin A metabolite retinoic acid (RA) in-homing receptors, particularly the integrin 47 and
duced gut-homing receptors and the ability to migrateCCR9, the receptor for TECK/CCL25, a chemokine ex-
to the small intestine while simultaneously suppressingpressed in the small bowel. Consequently, these cells
the expression of skin-homing molecules. These effectsmigrate preferentially to the small intestine, whereas
were reproduced with a synthetic agonist on RA recep-T cell stimulation by cutaneous antigens induces ef-
tors of the RAR isotype. Importantly, many DC from PPfector cells expressing skin-homing receptors, such as
and MLN but few from PLN or the spleen expressed thecarbohydrate ligands for endothelial P- and E-selectin
prerequisite enzymes for oxidative conversion of vitaminand the chemokine receptors CCR4 and/or CCR10.
A to RA, and inhibitors of these enzymes rendered intes-In vivo studies have shown that the microenvironment
in which T cells encounter antigen somehow instructs tinal DC incapable of inducing 47high T cells. Consis-
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Figure 1. Schematic Diagram of Putative Im-
printing Signals that Direct Primed T Cells to
the Skin or Gut
When naive T cells are activated under the
influence of retinoic acid (RA), they acquire a
gut-homing phenotype with high expression
levels of 47 and CCR9. RA is produced by
dendritic cells (DC) in gut-associated lym-
phoid tissues (Iwata et al., 2004) and possibly
also by intestinal epithelium or other sources.
Simultaneously, RA suppresses T cell acqui-
sition of skin-homing molecules (E-/P-selec-
tin ligands and CCR4). It has not yet been
determined if DC from peripheral lymph nodes
(PLN DC) generate specific imprinting signals
that promote T cell homing to the skin or other
nonintestinal organs.
tent with these in vitro experiments, vitamin A-deficient enzyme, RALDH1, to metabolize vitamin A, but it was
not determined if epithelial cells produce RA (Iwata etmice contained fewer 47high effector/memory T cells
than control animals. More importantly, T cells in the al., 2004). Conditional deletion of key enzymes for RA
production in DC or epithelium could clarify this point.lamina propria and intraepithelial compartment in the
small bowel of vitamin-A deficient mice were dramati- Another intriguing possibility is that RA produced by DC
and/or epithelial cells in the gut may become lymphcally reduced in number. Pending independent confir-
mation, this work represents a major advance in our borne and contribute remotely to intestinal imprinting in
draining MLN. This could explain why the in vivo induc-understanding of tissue-specific lymphocyte migration
(Figure 1). tion of gut-homing T cells is highly efficient in MLN even
though in our hands (and consistent with data shownLike all significant discoveries, these findings raise
many new questions and intriguing possibilities. For ex- by Iwata et al.), purified DC from MLN are less efficient
at inducing 47 than those from PP (our unpublishedample, although the current data show that vitamin
A-derived RA is both necessary and sufficient to induce data).
An analysis of mRNA levels for different isoenzymesT cell homing to the small intestine under steady-state
conditions, it remains to be determined if RA is required involved in RA production further suggests that DC re-
siding in MLN are surprisingly distinct from those in PPto generate gut-homing T cells in pathological settings.
Indeed, viral infections generate effector cells that mi- (Iwata et al., 2004). Since DC are thought to travel from
PP and the lamina propria to MLN via the lymph, it willgrate to the intestine regardless of the site of activation
or tissue of origin (Masopust et al., 2004). Perhaps in- be interesting to assess if the relocating DC adjust their
enzyme repertoire for RA production. Moreover, it re-flammatory conditions induce RA-producing enzymes
in DC that reside in nonintestinal compartments? Alter- mains to be determined if the differential expression of
these isoenzymes has functional consequences fornatively, it cannot be excluded that RA-independent
mechanisms are evoked that promote gut tropism under T cell imprinting. Experiments along these lines might
also provide clues to the question how DC are “edu-these conditions. Of note in this regard, thymocytes and
naive CD8 T cells express high levels of CCR9 but very cated” to acquire a gut-imprinting potential. Although it
is conceivable that DC or their precursors arrive in thelow levels of 47 (Carramolino et al., 2001; Mora et al.,
2003). This dissociation of homing receptor expression gut already committed to a “gut-imprinting program,” it
seems more likely that they acquire this property in thesupports the idea that there might be additional signals
that may function separately or together with RA to regu- intestine. It will be interesting to elucidate the role of gut-
associated cytokines, exposure to specific commensallate gut-homing receptors on T cells.
While intestinal DC are clearly capable of producing microorganisms, toll-like receptor signals, and other en-
vironmental cues in this regard.RA, it is not clear if they are the only source of RA
in vivo or if DC-derived RA is even necessary for T cell What are the implications of the observations by Iwata
et al. for our understanding of lymphocyte homing speci-imprinting. The data by Iwata et al. (2004) indicate that
intestinal epithelial cells express at least one relevant ficity in other tissues? For example, the colon, unlike
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the small intestine, is still poorly understood with regard tic effect of retinoids in T cell-mediated cutaneous auto-
immune diseases like psoriasis (Kuenzli and Saurat, 2001).to T cell recruitment. While 47 is likely to play a role,
it is clear that at least the chemokine signal(s) for this
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RA not only upregulated gut-homing molecules on
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